No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
98 |
4. Check minimum number of eventsNone |
98 |
5. Include endpointsNone |
98 |
6. Filter based on genotype QC (FinnGen only) |
98 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E87
- Name in latin
- Incrementum voluminis liquoris
Similar endpoints
↥List of similar endpoints to
Fluid overload
based on the number of shared cases.
Similar with more cases:
- Other disorders of fluid, electrolyte and acid-base balance
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 582 | 293 | 287 |
| Only index persons | 524 | 263 | 261 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 69.82 | 72.88 | 66.78 |
| Only index persons | 69.84 | 72.88 | 66.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 98 | 46 | 52 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 63.74 | 68.23 | 59.78 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 88
- Matched controls
- 879
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E87.7
ICD-10 Finland
Fluid overload
+∞
126.7
88
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
247.0
33.2
32
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
35.2
32.1
42
22
C03CA01
ATC
furosemide; systemic
17.6
31.0
70
159
TK800
NOMESCO Finland
Hemodialysis
117.4
30.1
31
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
73.8
30.0
33
7
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
55.7
26.0
30
8
I50.9
ICD-10 Finland
Heart failure, unspecified
14.4
24.1
46
62
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
162.5
23.9
24
*
N18.8
ICD-10 Finland
Other chronic renal failure
37.0
23.8
30
12
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
+∞
21.8
20
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
136.0
20.6
21
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
9.8
20.2
50
104
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
10.9
19.1
41
65
TPX10
NOMESCO Finland
Implantation of vascular injection port
85.0
18.6
20
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.7
18.3
70
271
A12AA04
ATC
calcium carbonate; oral
54.2
18.2
21
5
N18.0
ICD-10 Finland
End-stage renal disease
+∞
17.2
16
*
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
207.8
17.1
17
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
17.1
16.8
27
22
B03XA02
ATC
darbepoetin alfa; parenteral
30.1
16.0
21
9
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
18.9
15.7
24
17
J18.9
ICD-10 Finland
Pneumonia, unspecified
7.0
15.3
47
123
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.8
15.2
36
64
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
51.8
14.7
17
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
23.0
14.2
20
11
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
14.5
14.1
24
22
A10AE04
ATC
insulin glargine; parenteral
10.9
14.0
28
36
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
48.1
13.7
16
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
9.8
13.6
29
42
A11CC03
ATC
alfacalcidol; systemic
27.8
13.5
18
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
14.4
13.5
23
21
SPAT1262
SPAT
Handing over of treatment supplies
7.0
13.4
38
86
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
59.5
13.3
15
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
59.5
13.3
15
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
16.8
13.3
21
16
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.3
13.0
31
54
E87.5
ICD-10 Finland
Hyperkalaemia
+∞
12.8
12
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
150.6
12.8
13
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
18.2
12.5
19
13
SPAT1148
SPAT
Treatment of chronic ulcer or burn
7.3
12.4
33
67
215
Kela drug reimbursment
Diabetes, non-insulin-treated
5.8
12.4
44
130
103
Kela drug reimbursment
Diabetes, insulin-treated
5.5
12.2
46
146
N19
ICD-10 Finland
Unspecified kidney failure
24.0
11.6
16
8
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
10.0
11.3
23
30
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
32.8
11.1
14
5
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.2
11.1
33
77
A46
ICD-10 Finland
Erysipelas
6.8
11.0
30
62
M04AA01
ATC
allopurinol; systemic
6.6
11.0
31
67
C07AB07
ATC
bisoprolol; oral
4.9
11.0
64
308
XF600
NOMESCO Finland
Bloodpressure measurement
10.1
11.0
22
28
M10.9
ICD-10 Finland
Gout, unspecified
11.4
10.7
20
22
V03AE01
ATC
polystyrene sulfonate; oral
124.2
10.7
11
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
124.2
10.7
11
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
12.4
10.7
19
19
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
30.1
10.1
13
5
A10AE05
ATC
insulin detemir; parenteral
13.7
10.1
17
15
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
17.8
9.9
15
10
Z94.0
ICD-10 Finland
Kidney transplant status
62.1
9.9
11
*
137
Kela drug reimbursment
Uraemia requiring dialysis
62.1
9.9
11
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
62.1
9.9
11
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
8.3
9.8
22
34
I50.0
ICD-10 Finland
Congestive heart failure
8.3
9.8
22
34
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
4.9
9.7
37
113
L04AA06
ATC
mycophenolic acid; systemic
34.3
9.7
12
*
S97
ICPC
Chronic ulcer skin
11.0
9.6
18
20
J01FF01
ATC
clindamycin; systemic
4.6
9.5
41
141
D64.9
ICD-10 Finland
Anaemia, unspecified
7.1
9.5
24
44
B01AB10
ATC
tinzaparin; parenteral
10.5
9.4
18
21
R50.9
ICD-10 Finland
Fever, unspecified
5.3
9.3
31
81
C08CA01
ATC
amlodipine; oral
4.2
9.3
50
208
Z49.2
ICD-10 Finland
Other dialysis
41.4
9.3
11
*
WX204
NOMESCO Finland
Axillary plexus blockaced
12.7
9.2
16
15
R06.0
ICD-10 Finland
Dyspnoea
4.4
9.1
41
146
A10AA02
ATC
NA
16.3
9.0
14
10
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
16.3
9.0
14
10
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
4.9
8.9
33
96
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
7.2
8.9
22
39
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
55.7
8.9
10
*
A10AA01
ATC
NA
22.8
8.7
12
6
127
Kela drug reimbursment
Transplant complication
31.0
8.7
11
*
H04AA01
ATC
glucagon; nasal, parenteral
31.0
8.7
11
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
99.2
8.6
9
*
V03AE02
ATC
sevelamer; oral
99.2
8.6
9
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
99.2
8.6
9
*
A10BH05
ATC
linagliptin; oral
16.7
8.5
13
9
V03AE03
ATC
lanthanum carbonate; oral
+∞
8.5
8
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
37.1
8.3
10
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
24.8
8.2
11
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.9
8.2
45
187
I25.1
ICD-10 Finland
Atherosclerotic heart disease
4.5
8.2
32
98
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
8.9
8.1
17
23
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
12.5
8.1
14
13
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
7.5
8.1
19
31
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
6.9
8.0
20
36
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.9
8.0
41
161
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
10.4
7.9
15
17
H02AB06
ATC
prednisolone; systemic
3.7
7.9
56
282
X59
ICD-10 Finland
Exposure to unspecified factor
4.4
7.8
31
96
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
27.8
7.8
10
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.9
7.7
22
47
WX892
NOMESCO Finland
Monitored bed care
6.8
7.6
19
34
EBA15
NOMESCO Finland
Extraction of large number of teeth
10.9
7.6
14
15
NHQ40
NOMESCO Finland
Amputation of toe
87.1
7.5
8
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
+∞
7.4
7
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
7.4
7
*
H05BX01
ATC
cinacalcet; oral
+∞
7.4
7
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
+∞
7.4
7
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
7.2
37
142
WW500
NOMESCO Finland
Blood transfusion
9.6
7.1
14
17
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
15.5
7.1
11
8
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
12.4
7.0
12
11
J01MA12
ATC
levofloxacin; systemic
4.0
7.0
32
111
H3603, E103
ICD-10 Finland
NA
43.5
6.9
8
*
B05DB
ATC
Hypertonic solutions
43.5
6.9
8
*
B05DA
ATC
Isotonic solutions
43.5
6.9
8
*
JN4AD
NOMESCO Finland
Body CT examination
7.3
6.9
16
26
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.2
6.8
28
88
T89
ICPC
Diabetes insulin dependent
11.4
6.8
12
12
C03DA01
ATC
spironolactone; oral
5.2
6.7
21
50
J01MA14
ATC
moxifloxacin; systemic
5.4
6.7
20
45
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
7.0
6.7
16
27
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
15.9
6.6
10
7
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
75.1
6.5
7
*
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
75.1
6.5
7
*
E86
ICD-10 Finland
Volume depletion
75.1
6.5
7
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
75.1
6.5
7
*
A02BC02
ATC
pantoprazole; systemic
3.5
6.5
68
433
R60.9
ICD-10 Finland
Oedema, unspecified
12.4
6.5
11
10
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
12.4
6.5
11
10
T90
ICPC
Diabetes non-insulin dependent
3.7
6.5
33
123
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
19.8
6.4
9
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.7
6.4
18
38
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.5
6.4
23
64
WX213
NOMESCO Finland
Lower leg blockade
+∞
6.3
6
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
+∞
6.3
6
*
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
+∞
6.3
6
*
M10.3
ICD-10 Finland
Gout due to impairment of renal function
+∞
6.3
6
*
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
+∞
6.3
6
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
+∞
6.3
6
*
ZX108
NOMESCO Finland
Inhalation
+∞
6.3
6
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
+∞
6.3
6
*
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
4.2
6.3
25
76
A41.9
ICD-10 Finland
Sepsis, unspecified
13.9
6.3
10
8
R4110
NOMESCO Finland
Physiotherapy
3.5
6.2
35
141
SPAT1255
SPAT
Intravenous administration of medicine
8.3
6.2
13
18
B01AA03
ATC
warfarin; systemic
3.7
6.2
30
109
C09AA02
ATC
enalapril; systemic
3.9
6.1
27
90
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.9
6.1
27
90
JN3AD
NOMESCO Finland
Abdominal CT examination
6.1
6.1
16
31
I50.1
ICD-10 Finland
Left ventricular failure
9.1
6.1
12
15
WX002
NOMESCO Finland
Sedation and analgesia
3.8
6.1
27
91
C07AB02
ATC
metoprolol; systemic
3.7
6.0
29
104
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
16.5
6.0
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1616796) Gas panel - Central venous blood
37
11
53.43
60.48
12.4
2.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
32
13
36.07
47.04
15.5
1.7
mmol/l
2.6
2.4
—
25
8
(3013290) Carbon dioxide [Partial pressure] in Blood
32
13
36.07
47.04
15.6
1.7
kpa
4.9
4.8
0.22
32
13
(3027315) Oxygen [Partial pressure] in Blood
32
13
36.07
47.04
15.6
1.7
kpa
8.7
8.8
0.04
32
13
(40767503) Oxygen content in Capillary blood by calculation
33
16
30.59
45.44
7.5
2.1
%
14.7
15.9
—
21
8
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
41
33
20.64
44.73
18.4
4.8
mmol/l
23.4
25.3
1.55
41
33
(3028271) Lactate [Moles/volume] in Capillary blood
29
11
37.02
43.42
5.3
1.8
mmol/l
1.3
1.6
0.56
29
11
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
43
15.03
36.23
9.6
3.0
mmol/l
2.3
2.1
0.07
30
33
(3009343) pH of Capillary blood
41
46
14.60
36.10
9.5
2.9
ph
7.4
7.4
—
18
6
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
49
73
12.42
35.18
10.2
3.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
25
12
27.63
34.04
6.2
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
8
61.00
29.04
16.8
2.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
70
192
10.26
28.80
20.6
4.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
30
29
14.47
28.60
9.8
2.8
mmol/l
24.4
24.4
0.02
22
24
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
12
23.35
28.19
2.1
1.2
u/ml
232.0
296.2
—
17
5
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
23
15.82
27.71
2.9
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
54
118
8.97
27.20
4.5
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
15
18.62
25.31
2.6
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
13
20.29
25.31
2.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
54
126
8.32
25.29
3.8
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
45
87
8.72
25.08
3.1
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
21
14
18.82
24.39
2.6
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
51
116
8.08
24.34
3.3
2.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
38
63
9.22
24.13
41.9
2.7
mmol/l
1.2
1.2
2.09
38
55
(3017143) Hepatitis C virus Ab [Presence] in Serum
46
95
8.24
24.01
4.0
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
37
61
9.14
23.56
4.8
4.0
e9/l
76.6
70.2
0.46
32
49
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
107
7.83
23.20
3.8
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
22
18
15.47
22.87
3.6
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
21
14.00
22.41
3.1
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
27
9
40.61
21.98
4.3
1.3
%
88.9
90.1
—
27
9
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
59
172
7.11
21.45
3.8
2.0
mg/l
3.3
3.0
0.65
52
148
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
33
54
8.71
20.95
2.6
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
15
15.47
20.02
3.4
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
69
247
7.06
19.68
12.8
5.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
23
12.04
19.53
1.9
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
32
55
8.15
19.35
6.8
3.8
%
0.6
0.2
0.68
15
12
(3032080) INR in Blood by Coagulation assay
75
294
7.61
19.22
39.7
7.9
inr
1.3
1.2
0.67
38
79
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
12
16.93
18.96
5.4
4.4
%
62.9
60.3
0.32
17
12
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
12
16.93
18.96
3.7
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
31
53
8.09
18.79
17.3
6.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
34
65
7.48
18.60
15.1
3.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
83
366
9.28
18.48
43.8
6.4
mmol/l
1.2
1.2
2.25
65
312
(3026250) Tacrolimus [Mass/volume] in Blood
17
0
+∞
18.29
59.2
0.0
ug/l
7.5
—
—
17
0
(3036525) Urea [Moles/time] in 24 hour Urine
17
0
+∞
18.29
2.2
0.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
23
11.35
18.00
3.2
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
32
60
7.43
17.76
7.9
4.1
%
0.1
0.2
0.11
17
19
(3017181) Myelocytes/100 leukocytes in Blood
33
65
7.15
17.46
7.7
3.9
%
1.2
0.8
0.44
17
22
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
65
239
6.11
17.40
5.8
3.2
ng/l
9881.1
1231.3
3.25
58
207
(3028026) IgM [Mass/volume] in Serum or Plasma
27
43
8.29
17.32
3.1
1.7
g/l
3.1
1.1
0.70
22
36
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
12
15.74
17.21
5.3
4.4
e9/l
5.0
3.8
0.91
16
12
(36304419) Bacteria [Presence] in Urine
61
219
5.73
16.60
12.0
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
62
229
5.65
16.22
12.3
2.6
e6/l
0.7
0.5
0.45
54
170
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
70
291
5.92
15.74
13.2
3.6
ng/l
81.8
38.1
1.29
63
214
(3044640) Blood type and Crossmatch panel - Blood
59
214
5.42
15.64
4.1
2.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
91
5.93
15.41
3.8
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
62
237
5.40
15.34
34.2
2.8
ph
7.4
7.4
0.01
35
44
(3022096) Basophils/100 leukocytes in Blood
75
337
6.22
15.18
16.6
6.0
%
0.5
0.6
1.94
75
315
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
36
88
5.89
15.06
3.9
1.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
14
0
+∞
14.97
2.2
0.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
0
+∞
14.97
4.6
0.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
76
349
6.25
14.88
16.5
5.9
%
2.9
2.8
0.10
76
327
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
43
7.46
14.85
2.0
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
76
350
6.22
14.80
16.6
6.3
%
9.0
8.7
0.28
76
330
(3002582) Erythrocytes [#/volume] in Urine
63
250
5.26
14.72
13.7
2.7
e6/l
13.1
40.6
1.09
57
193
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
69
295
5.52
14.67
14.3
2.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
76
358
6.00
14.16
16.5
6.0
%
20.8
27.4
6.70
76
335
(3018010) Neutrophils/100 leukocytes in Blood
75
353
5.79
13.89
15.1
5.7
%
64.3
57.3
5.70
75
334
(3025159) Blasts/100 leukocytes in Blood
28
58
6.36
13.85
8.2
4.2
%
0.0
0.5
0.48
15
16
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
12
13.44
13.83
1.4
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
58
224
4.89
13.80
12.9
3.6
mg/mmol
69.9
6.5
2.56
52
129
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
13
12.40
13.16
2.6
1.3
—
—
—
0
0
(3013512) EKG study
57
225
4.67
13.00
8.2
3.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
62
262
4.72
12.88
7.4
2.7
u/l
65.5
56.6
0.50
57
238
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
47
162
4.65
12.77
2.5
1.6
mg/l
1.2
1.5
0.54
40
125
(3019309) Folate [Moles/volume] in Red Blood Cells
44
146
4.65
12.52
3.1
1.8
nmol/l
1725.4
1258.8
0.90
31
106
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
6
31.45
12.50
3.8
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
64
284
4.61
12.28
14.3
3.3
e6/l
28.9
64.5
1.06
58
210
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
12
12.34
12.22
2.7
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
13
11.38
11.59
5.8
4.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
8
23.53
11.57
3.9
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
53
212
4.27
11.56
9.6
2.9
mg/l
345.6
31.6
2.36
47
129
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
25
8.02
11.42
2.4
2.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
14
16
10.04
11.40
1.0
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
16
10.04
11.40
2.6
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
31
85
4.87
11.05
7.4
12.0
mmol/l
2.4
1.5
0.25
19
69
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
43
153
4.23
10.92
3.8
2.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
15
20
8.67
10.88
2.2
2.1
%
99.1
85.3
1.02
15
20
(3004119) Hemoglobin [Mass/volume] in Venous blood
19
37
6.13
9.81
8.3
3.2
g/l
126.6
128.7
0.11
19
37
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
67
342
4.03
9.81
7.3
4.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
23
54
5.26
9.74
3.0
1.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
14
8
20.10
9.73
2.2
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
6
24.63
9.64
1.6
2.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
45
178
3.83
9.63
14.6
5.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
50
214
3.73
9.48
9.9
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
65
332
3.84
9.36
64.9
9.0
e9/l
0.0
0.0
1.08
59
266
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
14
9
17.86
9.35
1.4
2.0
pg
34.5
33.7
—
14
9
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
9
17.86
9.35
2.6
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
84
513
5.46
9.33
14.0
4.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
52
5.17
9.22
2.2
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
28
82
4.38
9.04
1.9
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
69
381
3.74
8.51
9.6
3.3
estimate
0.0
0.0
0.00
30
69
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
8
0
+∞
8.45
8.0
0.0
ug/min
30.8
—
—
8
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
8
0
+∞
8.45
10.5
0.0
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
8
0
+∞
8.45
4.1
0.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
7
19.27
8.31
1.6
2.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
68
376
3.64
8.29
11.1
4.2
estimate
0.0
0.0
0.00
34
71
(3012441) Differential panel - Pleural fluid
11
5
24.49
8.21
1.9
2.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
14
8.72
8.16
1.4
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
68
379
3.59
8.12
9.6
3.3
estimate
0.0
0.0
0.00
34
73
(3022313) Gas panel - Capillary blood
16
32
5.78
7.97
13.2
3.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
12
18
7.46
7.80
2.5
2.8
%
226.5
196.9
0.27
12
18
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
25
6.37
7.79
2.2
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
50
236
3.28
7.77
7.4
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
48
222
3.28
7.70
10.2
3.8
estimate
0.0
0.0
0.00
15
67
(3007164) IgA [Mass/volume] in Serum or Plasma
37
147
3.44
7.59
2.7
1.3
g/l
3.0
2.7
0.24
29
87
(3027273) Bicarbonate [Moles/volume] in Venous blood
15
30
5.72
7.45
17.4
2.9
mmol/l
25.5
24.9
0.20
15
30
(3024932) HLA-DR beta [Type]
7
0
+∞
7.38
1.0
0.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
0
+∞
7.38
3.4
0.0
—
—
—
0
0
(3024471) HLA-A [Type]
7
0
+∞
7.38
1.0
0.0
—
—
—
0
0
(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid
7
0
+∞
7.38
2.4
0.0
g/l
1.0
—
—
7
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
55
281
3.18
7.37
2.5
1.9
pmol/l
104.6
97.9
0.31
31
141
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
15
32
5.35
6.95
6.5
2.0
%
1.7
1.2
0.59
15
32
(3015736) pH of Urine
55
288
3.07
6.95
6.5
3.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
9
13.57
6.76
1.5
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
18
6.76
6.58
1.5
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
20
58
4.08
6.41
2.7
12.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
56
306
2.94
6.40
9.9
3.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
40
4.59
6.17
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
50
4.18
6.09
3.8
2.4
ml/min/173m2
28.5
74.1
5.47
13
19
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
20
6.07
5.95
4.0
2.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
17
6.44
5.75
3.8
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
21
5.77
5.67
1.4
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
25
92
3.31
5.63
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
5
17.23
5.51
1.1
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
30
4.84
5.48
10.5
3.4
%
46.3
54.1
0.38
13
30
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
18
6.07
5.44
2.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
18
6.07
5.44
2.6
1.3
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
5
0
+∞
5.25
3.6
0.0
mmol/l
19.8
—
—
5
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
0
+∞
5.25
1.2
0.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
0
+∞
5.25
5.0
0.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
5
0
+∞
5.25
3.6
0.0
umol/l
444.0
—
—
5
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
6
14.35
5.17
1.3
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
63
3.50
4.99
1.5
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
12
28
4.74
4.98
18.2
3.4
mmol/l
25.1
25.0
0.04
12
28
(3023419) Bacteria identified in Sputum by Culture
9
10
9.76
4.90
6.2
3.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
10
9.76
4.90
7.6
1.2
%
78.1
60.2
—
9
10
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
28
119
2.89
4.89
4.8
2.5
e6/l
3.9
1.7
0.40
15
63
(4035726)
19
65
3.39
4.76
2.0
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
8
10.75
4.61
1.3
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
6
12.42
4.34
1.0
1.0
—
—
—
0
0
(4062490)
7
6
12.42
4.34
1.4
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
29
137
2.59
4.08
4.7
2.3
e6/l
0.7
1.0
0.51
16
81
(3000093) Morphology [Interpretation] in Blood Narrative
7
7
10.64
4.08
1.1
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
7
10.64
4.08
1.3
1.9
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
15
6.48
3.91
1.1
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
6
5
12.65
3.81
2.2
1.2
e6/l
575.2
1079.4
—
6
5
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
6
5
12.65
3.81
7.5
7.8
nmol/l
613.0
662.8
—
6
5
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
5
12.65
3.81
10.2
9.8
nmol/l
1319.8
1084.0
—
6
5
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
16
6.07
3.75
1.6
1.4
mg/l
10.6
11.0
—
9
16
(3019225) pH of Specimen
17
63
3.05
3.72
34.5
3.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
6
10.54
3.54
3.5
2.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
6
10.54
3.54
1.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
34
185
2.28
3.46
18.4
6.9
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
6
7
9.03
3.31
1.2
1.7
mmol/l
7.2
6.8
—
6
7
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
75
567
2.38
3.31
5.1
3.8
pmol/l
14.8
14.9
0.14
70
515
(3052851) Hemolysis interference index of Serum or Plasma
10
29
3.73
3.14
7.0
4.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
6
8
7.89
3.10
1.5
1.3
u/l
93.2
173.7
—
6
8
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
35
3.41
3.03
16.3
24.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
36
3.32
2.91
5.9
2.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
9
7.01
2.91
1.5
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
36
214
2.08
2.87
1.8
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
18
4.74
2.86
1.0
1.5
—
—
—
0
0
(4306422)
6
10
6.31
2.74
1.5
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
68
0.00
2.73
0.0
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
25
3.85
2.65
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
86
718
2.62
2.60
80.5
12.8
ml/min/173m2
48.1
79.7
10.68
81
594
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
11
5.73
2.58
1.3
4.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
7
7.45
2.58
3.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
39
3.05
2.57
3.8
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
6
12
5.25
2.44
10.2
2.7
mmol/l
7.9
6.6
—
6
12
(3008037) Lactate [Moles/volume] in Venous blood
6
12
5.25
2.44
10.2
2.7
mmol/l
1.1
1.6
—
6
12
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
22
3.86
2.42
1.4
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
17
4.35
2.40
3.3
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
8
6.51
2.40
1.2
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
9
5.78
2.24
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
9
5.78
2.24
1.6
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
9
5.78
2.24
1.6
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
9
5.78
2.24
1.6
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
24
3.53
2.23
2.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
29
173
1.96
2.23
1.5
1.3
u/ml
9.3
1.0
0.44
11
40
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
30
3.20
2.21
3.7
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
10
5.20
2.09
1.8
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
32
2.99
2.06
1.9
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
83
706
2.15
2.00
50.0
14.5
%
35.0
40.5
7.85
45
492
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
16
3.92
1.96
2.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
11
4.72
1.96
3.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
11
4.72
1.96
3.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
11
4.72
1.96
3.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
11
4.72
1.96
3.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
11
4.72
1.96
3.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
12
4.33
1.84
3.4
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
12
4.33
1.84
1.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
27
167
1.85
1.84
5.0
3.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
18
3.48
1.77
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
18
3.48
1.77
1.3
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
77
649
1.87
1.75
93.9
17.1
%
14.9
13.7
7.80
77
634
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
48
0.00
1.75
0.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
31
2.72
1.70
3.3
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
67
548
1.70
1.63
11.0
3.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
57
453
1.62
1.50
4.9
2.8
—
—
—
0
0
(3002256) Pathology report gross observation
17
98
1.89
1.42
1.4
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
90
821
2.18
1.41
84.4
12.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
17
3.04
1.37
1.4
1.8
—
—
—
0
0
(3020891) Body temperature
8
35
2.40
1.30
4.0
3.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
18
2.87
1.30
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
36
2.33
1.27
1.6
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
57
668
0.65
1.24
79.5
18.2
g/l
326.2
332.8
5.93
57
663
(1761482) Bacteria [#/volume] in Urine by Culture
5
19
2.72
1.23
8.8
3.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15
236
0.57
1.18
3.1
4.5
%
27.4
20.1
—
5
110
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
5
20
2.58
1.16
1.0
2.0
—
11275.8
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
33
2.21
1.08
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
37
283
1.49
1.07
2.5
2.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
22
2.34
1.04
1.2
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
12
69
1.84
1.02
2.9
2.1
ug/l
40.8
5.0
0.45
12
63
(3001019) Free T4 and TSH panel - Serum or Plasma
0
28
0.00
0.99
0.0
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
55
1.91
0.96
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
35
273
1.44
0.89
4.2
2.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
124
1.55
0.82
1.1
1.3
iu/ml
40.2
20.4
—
5
40
(3022621) pH of Urine by Test strip
9
53
1.77
0.78
6.7
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
84
1.63
0.76
1.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
39
1.85
0.74
1.9
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
26
1.97
0.71
1.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
26
1.97
0.71
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
91
0.53
0.71
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
28
1.83
0.67
1.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
28
1.83
0.67
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
28
1.83
0.67
1.2
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
23
0.00
0.59
0.0
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
75
1.53
0.53
13.4
3.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
6.4
—
0
10
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
2.7
—
0
7
(1002224) Polysomnography panel
5
34
1.50
0.41
1.0
1.1
—
—
—
0
0
(4010399)
8
61
1.34
0.40
1.1
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
35
1.45
0.40
2.4
2.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
51
1.40
0.32
1.1
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
1.1
—
0
5
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
14
118
1.22
0.20
1.1
1.3
u/ml
26.4
10.1
—
7
48
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
1.1
—
0
8
(3000492) Spirometry study
8
67
1.21
0.17
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
81
1.12
0.15
1.7
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
73
1.10
0.08
1.6
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
18
190
0.94
0.04
7.8
3.4
kg/l
1.0
1.0
—
5
20
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
74
743
0.98
0.00
8.3
4.6
mmol/l
6.8
6.0
2.40
69
666
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
104
0.96
0.00
1.7
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(4281824)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
99
0.90
0.00
20.1
6.8
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
8.8
—
0.7
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
7
79
0.88
0.00
4.4
2.5
nmol/l
16.8
13.9
—
7
72
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_FLUIDOVER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_FLUIDOVER | 3.281 [1.98, 5.44] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.135 |
During the follow-up period (1.1.1998 — 31.12.2019), 103 out of 212 females with E4_FLUIDOVER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_FLUIDOVER | 6.861 [3.77, 12.48] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.098 |
During the follow-up period (1.1.1998 — 31.12.2019), 127 out of 212 males with E4_FLUIDOVER died.
Mortality risk
Mortality risk for people of age
years, who have E4_FLUIDOVER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.229% | 1.763% |
| 5 | 1.508% | 9.368% |
| 10 | 4.476% | 22.161% |
| 15 | 8.006% | 39.888% |
| 20 | 13.834% | 56.64% |
Relationships between endpoints
↥Index endpoint: E4_FLUIDOVER – Fluid overload
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data